GlassScriptPhysician profile
Emily S Steinbis
NPI 1558688549
$1,202.23
in general payments reported to CMS, 2019-2025
20 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $46.70 · 2021: $126 · 2022: $73.13 · 2023: $382 · 2024: $27.73 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.76 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $170.23 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $125.12 | 2019 | |
| Intuitive Surgical, INC. | $98.67 | 2023 | Da Vinci Surgical System |
| Coopersurgical, INC. | $87.62 | 2020-2023 | Paragard T 380a |
| Hologic Sales and Service, LLC | $73.30 | 2019-2025 | Acessa Provu System |
| Merck Sharp & Dohme LLC | $69.41 | 2019-2025 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $44.65 | 2023-2025 | |
| Evofem Biosciences, INC. | $35.79 | 2021-2022 | |
| Myovant Sciences INC. | $35.59 | 2021-2022 | |
| Glaxosmithkline, LLC. | $35.26 | 2020-2021 | |
| Minerva Surgical, INC | $34.67 | 2019 | |
| Biogen, INC. | $32.63 | 2025 | Zurzuvae |
| Organon LLC | $30.89 | 2021-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $30.64 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $28.09 | 2025 | Myfembree |
| Baxter Healthcare | $23.98 | 2023 | Tisseel |
| Aspira Women'S Health INC | $22.37 | 2023 | Ova1 |
| Pfizer INC. | $15.31 | 2025 | |
| Agile Therapeutics, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Steinbis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.